Emergent BioSolutions Inc.
DE ˙ DB ˙ US29089Q1058
6,70 € ↓ -0,51 (-7,07%)
2026-06-03
AKTIENPREIS
SecurityDE:ER4 / Emergent BioSolutions Inc.
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership1,003,912 shares
Latest Disclosed Value $ 8,332,470
D. E. Shaw & Co., Inc. ownership in ER4 / Emergent BioSolutions Inc.

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 1,003,912 shares of Emergent BioSolutions Inc. (DE:ER4) valued at $7,081,595 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 723,217 shares of Emergent BioSolutions Inc.. This represents a change in shares of 38.81% during the quarter. The current value of the position is $6,726,210 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (ER4) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:ER4 / Emergent BioSolutions Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 1,003,912 280,695 38.81 8,332 -6.78 0.0037
2026-02-17 2025-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 723,217 402,050 125.18 8,939 215.61 0.0049
2025-11-14 2025-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 321,167 -90,201 -21.93 2,833 7.93 0.0016
2025-08-14 2025-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 411,368 139,094 51.09 2,625 98.34 0.0019
2025-05-15 2025-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 272,274 -110,769 -28.92 1,323 -63.86 0.0012
2025-02-14 2024-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 383,043 -388,095 -50.33 3,662 -43.14 0.0027
2024-11-14 2024-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 771,138 -56,658 -6.84 6,439 14.07 0.0055
2024-08-14 2024-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 827,796 411,132 98.67 5,646 435.58 0.0053
2024-05-15 2024-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 416,664 -769,888 -64.88 1,054 -62.98 0.0009
2024-02-14 2023-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 1,186,552 250,034 26.70 2,848 -10.58 0.0025
2023-11-14 2023-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 936,518 -41,399 -4.23 3,184 -55.70 0.0033
2023-08-14 2023-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 977,917 -385,863 -28.29 7,188 -49.13 0.0073
2023-05-15 2023-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 1,363,780 -267,838 -16.42 14,129 -26.68 0.0151
2023-02-14 2022-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 1,631,618 639,405 64.44 19,269 -7.48 0.0213
2022-11-14 2022-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 992,213 -73,734 -6.92 20,826 -37.06 0.0249
2022-08-15 2022-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 1,065,947 -97,639 -8.39 33,087 -30.75 0.0388
2022-05-16 2022-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 1,163,586 218,248 23.09 47,777 16.27 0.0447
2022-02-14 2021-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 945,338 882,893 1,413.87 41,093 1,214.13 0.0341
2021-11-15 2021-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 62,445 52,852 550.94 3,127 417.72 0.0028
2021-08-16 2021-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 9,593 9,593 604 0.0005
2021-05-17 2021-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 0 -12,991 -100.00 0 -100.00
2021-02-16 2020-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 12,991 12,991 1,164 0.0010
2020-11-16 2020-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 0 -7,954 -100.00 0 -100.00
2020-08-14 2020-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 7,954 -37,703 -82.58 629 -76.18 0.0007
2020-05-15 2020-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 45,657 -51,701 -53.10 2,641 -49.71 0.0041
2020-02-14 2019-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 97,358 -17,857 -15.50 5,252 -12.80 0.0060
2019-11-14 2019-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 115,215 76,298 196.05 6,023 220.37 0.0074
2019-08-14 2019-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 38,917 -26,555 -40.56 1,880 -43.17 0.0023
2019-05-15 2019-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 65,472 -35,103 -34.90 3,308 -44.52 0.0043
2019-02-14 2018-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 100,575 -24,998 -19.91 5,962 -27.87 0.0082
2018-11-14 2018-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 125,573 -15,254 -10.83 8,266 16.26 0.0099
2018-08-14 2018-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 140,827 -38,420 -21.43 7,110 -24.66 0.0093
2018-05-15 2018-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 179,247 -66,332 -27.01 9,437 -17.31 0.0128
2018-02-14 2017-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 245,579 -51,702 -17.39 11,412 -5.10 0.0157
2017-11-14 2017-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 297,281 -79,631 -21.13 12,025 -5.92 0.0185
2017-08-14 2017-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 376,912 -28,399 -7.01 12,781 8.59 0.0211
2017-05-15 2017-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 405,311 -254,486 -38.57 11,770 -45.68 0.0207
2017-02-14 2016-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 659,797 126,148 23.64 21,668 28.78 0.0368
2016-11-14 2016-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 533,649 -308,924 -36.66 16,826 -28.98 0.0297
2016-08-15 2016-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 842,573 -49,303 -5.53 23,693 -26.92 0.0437
2016-05-16 2016-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 891,876 31,180 3.62 32,420 -5.85 0.0582
2016-02-16 2015-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 860,696 98,910 12.98 34,436 58.67 0.0513
2015-11-16 2015-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 761,786 114,028 17.60 21,703 1.68 0.0320
2015-08-14 2015-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 647,758 40,339 6.64 21,344 22.18 0.0318
2015-05-15 2015-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 607,419 46,301 8.25 17,469 14.33 0.0268
2015-02-17 2014-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 561,118 40,642 7.81 15,279 37.76 0.0196
2014-11-14 2014-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 520,476 29,729 6.06 11,091 0.63 0.0144
2014-08-14 2014-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 490,747 28,199 6.10 11,022 -5.71 0.0150
2014-05-15 2014-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 462,548 -10,426 -2.20 11,689 7.49 0.0167
2014-02-14 2013-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 472,974 4,904 1.05 10,874 21.95 0.0148
2013-11-20 2013-09-30 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 468,070 -32,756 -6.54 8,917 23.47 0.0142
2013-11-14 2013-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 468,070 8,917
2013-08-14 2013-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 500,826 500,826 7,222 0.0136
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-11-15 2021-09-30 13F EMERGENT BIOSOLUTIONS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F EMERGENT BIOSOLUTIONS COM Call 4,100 258 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.